Osteopontin – a fibrosis-related marker – in dilated cardiomyopathy in patients with Emery-Dreifuss muscular dystrophy

References

• Røsjø H, Omland T. New cardiovascular risk markers: the race is on, but are there any winners? Scand J Clin Lab Invest 2008;68:673–7.
   PubMed Web of Science ®Google Scholar
• Rosenberg M, Zugck C, Nelles M, Juenger C, Frank D, Remppis A, . Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail 2008;1:43–9.
   PubMed Web of Science ®Google Scholar
• Soejima H, Irie A, Fukunaga T, Oe Y, Kojima S, Kaikita K, . Osteopontin expression of circulating T cells and plasma osteopontin levels are increased in relation to severity of heart failure. Circ J 2007;71:1879–84.
   PubMed Web of Science ®Google Scholar
• Giachelli CM, Liaw L, Murry CE, Schwartz SM, Almeida M. Osteopontin expression in cardiovascular diseases. Ann NY Acad Sci 1995;760:109–26.
   PubMed Web of Science ®Google Scholar
• Singh K, Balligand JL, Fischer TA, Smith TW, Kelly RA. Glucocorticoids increase expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem 1995;270: 28471–8.
   PubMed Web of Science ®Google Scholar
• Ashizawa N, Graf K, Do YS, Nunohiro T, Giachelli CM, Meehan WP, Tuan TL, Hsuah WA. Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction. J Clin Invest 1996;98: 2218–27.
   PubMed Web of Science ®Google Scholar
• Okamoto H. Osteopontin and cardiovascular system. Mol Cell Biochem 2007;300:1–7.
   PubMed Web of Science ®Google Scholar
• Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Maenpas PH. Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties. J Biol Chem 1999;274:1729–35.
   PubMed Web of Science ®Google Scholar
• Mukherjee BB, Nemir M, Beninati S, Cordella-Miele E, Singh K, Chackalaparampil I, . Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann NY Acad Sci 1995;760:201–12.
   PubMed Web of Science ®Google Scholar
• Satoh M, Nakamura M, Akatsu T. Myocardial osteopontin expression is associated with collage fibrillogenesis in human dilated cardiomyopathy. Eur J Heart Fail 2005;7: 755–62.
   PubMed Web of Science ®Google Scholar
• Yu Q, Vazquez R, Khojeinin EV, , Patel ChVenkataramani R, Larson DF. IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am J Physiol Heart Circ Physiol 2009;297:H76–H85.
   Web of Science ®Google Scholar
• Xie Z, Singh M, Siwik DA, Joyner WL, Singh K. Osteopontin inhibits interleukin-1β-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta. J Biol Chem 2003;278:48546–52.
   PubMed Web of Science ®Google Scholar
• Stawowy P, Blaschke F, Pfautsch P, Goetze S, Lippek F, Wollert-Wulf B, . Increased myocardial expression of osteopontin in patients with advanced heart failure. Eur J Heart Fail 2002;4:139–46.
   PubMed Web of Science ®Google Scholar
• Graf K, Do YS, Ashizawa N, Meehan WP, Giachelli CM, , Marboe ChC. Myocardial osteopontin expression is associated with left ventricular hypertrophy. Circulation 1997;96:3063–71.
   PubMed Web of Science ®Google Scholar
• Renault MA, Robbesyn F, Reant P, Doin V, Daret D, Allires C, . Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy. Circ Heart Fail 2010;3:431–9.
   PubMed Web of Science ®Google Scholar
• Williams EB, Halpert I, Wickline S, Davison G, Parks WC, Rottman JN. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation 1995;92:705–9.
   PubMed Web of Science ®Google Scholar
• Singh K, Sirokman G, Communal C, Robinson KG, Conrad CH, Brooks WW, . Myocardial osteopontin expression coincides with the development of heart failure. Hypertension 1999;33:663–70.
   PubMed Web of Science ®Google Scholar
• Trueblood NA, Xie Z, Communal C, Sam F, Ngoy S, Liaw L, . Exaggerated left ventricular dilatation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin. Circ Res 2001;88:1080–7.
   PubMed Web of Science ®Google Scholar
• Vetrone SA, Montecino-Rodriquez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, . Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cells subsets and intramuscular TGF-β. J Clin Invest 2009;119:1583–94.
   PubMed Web of Science ®Google Scholar
• Tamura A, Shingai M, Aso N, Hazuku T, Nasu M. Osteopontin is released from the heart into the coronary circulation in patients with a previous anterior wall myocardial infarction. Circ J 2003;67:742–4.
   PubMed Web of Science ®Google Scholar
• Suezawa C, Kusachi S, Murakami T, Toeda K, Hirohata S, Nakamura K, . Time dependent changes in plasma osteopontin levels in patients with anterior-wall acute myocardial infarction after successful reperfusion: correlation with left-ventricular volume and function. J Lab Clin Med 2005;145:33–40.
   PubMed Web of Science ®Google Scholar
• Minoretti P, Falcone C, Calcagnino M, Emanuele E, Buzzi MP, Coen E, Geroldi D. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina. Eur Heart J 2006;27:802–7.
   PubMed Web of Science ®Google Scholar
• Coskun S, Atalar E, Ozturk E, Yavuz B, Ozer N, Goker H, . Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes. J Natl Med Assoc 2006;98:1746–50.
   PubMed Web of Science ®Google Scholar
• Arnlöv J, Evans JC, Benjamin EJ, Larson MG, Levy D, Sutherland P, . Clinical and echocardiographic correlates of plasma osteopontin in the community. The Framingham Study. Heart 2006;92:1514–5.
   PubMed Web of Science ®Google Scholar
• Piva L, Gavassini BF, Fanin M, Bello L, Sorarŭ G, Ermani M, . Osteopontin in Duchenne muscular dystrophy. XII International Congress on Neuromuscular Diseases, Naples 2010:126–7.
   Google Scholar
• Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandoff R, Klingel K. A fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Cir Res 2009;105:851–9.
   Google Scholar
• Marchel M. Left ventricular function in patients with Emery-Dreifuss muscular dystrophy. MD PhD thesis. Warsaw Medical University, 2008:1–124.
   Google Scholar
• Niebroj-Dobosz I, Madej-Pilarczyk A, Marchel M, Sokołowska B, Hausmanowa-Petrusewicz I. Matrix metalloproteionases in serum of Emery-Dreifuss muscular dystrophy patients. Acta Biochim Pol 2009;56:717–22.
   PubMed Web of Science ®Google Scholar
• Niebroj-Dobosz I, Marchel M, Madej A, Sokołowska B, Hausmanowa-Petrusewicz I. Circulating autoantibodies to troponin I in Emery-Dreifuss muscular dystrophy. Acta Myol 2008;27:1–6.
   PubMedGoogle Scholar